Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Zanor MI et al. | Metabolic characterization of loci affecting sensory attributes in tomato allows an assessment of the influence of the levels of primary metabolites and volatile organic contents. | 2009 | J. Exp. Bot. | pmid:19346240 |
Kim YH et al. | Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. | 2009 | Acta Haematol. | pmid:19332985 |
Lindgren S et al. | Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. | 2009 | Scand. J. Gastroenterol. | pmid:19330567 |
Breborowicz A et al. | Intravenous iron sucrose changes the intraperitoneal homeostasis. | 2009 | Blood Purif. | pmid:19325240 |
Vanin S et al. | Seasonal variation of trehalose and glycerol concentrations in winter snow-active insects. | 2008 Nov-Dec | Cryo Letters | pmid:19280052 |
Muñoz M et al. | [Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients]. | 2009 | Med Clin (Barc) | pmid:19264195 |
Clark SF | Iron deficiency anemia: diagnosis and management. | 2009 | Curr. Opin. Gastroenterol. | pmid:19262200 |
Torres-Corzo JG et al. | Comparison of cerebrospinal fluid obtained by ventricular endoscopy and by lumbar puncture in patients with hydrocephalus secondary to neurocysticercosis. | 2009 | Surg Neurol | pmid:19249584 |
Pollak VE et al. | The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. | 2009 | BMC Nephrol | pmid:19245700 |
Haddad A et al. | Use of iron sucrose in dialysis patients sensitive to iron dextran. | 2009 | Saudi J Kidney Dis Transpl | pmid:19237805 |
Ibrahim HN et al. | Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients. | 2009 | Clin J Am Soc Nephrol | pmid:19211669 |
Kell DB | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. | 2009 | BMC Med Genomics | pmid:19133145 |
pmid:19066859 | ||||
Moon TS et al. | Production of glucaric acid from a synthetic pathway in recombinant Escherichia coli. | 2009 | Appl. Environ. Microbiol. | pmid:19060162 |
Yoon SH et al. | Cloning and characterization of uronate dehydrogenases from two pseudomonads and Agrobacterium tumefaciens strain C58. | 2009 | J. Bacteriol. | pmid:19060141 |
Gonçalves P et al. | The effect of high glucose on SERT, the human plasmalemmal serotonin transporter. | 2008 | Nutr Neurosci | pmid:19000377 |
Bolaños L et al. | Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients. | 2008 | Adv Perit Dial | pmid:18986009 |
Young RS | Determination of calcium oxide in calcined phosphate ores. | 1973 | Talanta | pmid:18961359 |
Lord RS and Bralley JA | Clinical applications of urinary organic acids. Part I: Detoxification markers. | 2008 | Altern Med Rev | pmid:18950247 |
pmid:18930421 | ||||
Yang Z et al. | Symbiosis between microorganisms from kombucha and kefir: Potential significance to the enhancement of kombucha function. | 2010 | Appl. Biochem. Biotechnol. | pmid:18810658 |
pmid:18786076 | ||||
Stefánsson BV et al. | Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection. | 2008 | Free Radic. Biol. Med. | pmid:18775775 |
Zółtaszek R et al. | [The biological role of D-glucaric acid and its derivatives: potential use in medicine]. | 2008 | Postepy Hig Med Dosw (Online) | pmid:18772850 |
pmid:18727354 | ||||
pmid:18720044 | ||||
Oleson L and Court MH | Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. | 2008 | J. Pharm. Pharmacol. | pmid:18718121 |
Anirban G et al. | The comparative safety of various intravenous iron preparations in chronic kidney disease patients. | 2008 | Ren Fail | pmid:18661414 |
Costa S et al. | In vitro evaluation of the chemoprotective action mechanisms of leontopodic acid against aflatoxin B1 and deoxynivalenol-induced cell damage. | 2009 | J Appl Toxicol | pmid:18636399 |
Kaplinsky C | Parenteral iron therapy. | 2008 | Isr. Med. Assoc. J. | pmid:18605363 |
Pinsk V et al. | Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. | 2008 | Isr. Med. Assoc. J. | pmid:18605353 |
Auerbach M and Ballard H | Intravenous iron in oncology. | 2008 | J Natl Compr Canc Netw | pmid:18597712 |
Cuenca J et al. | Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery. | 2008 | Anesthesiology | pmid:18580186 |
pmid:18571185 | ||||
Picker SM et al. | Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. | 2008 | Transfusion | pmid:18513255 |
Kuo KL et al. | Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. | 2008 | J. Am. Soc. Nephrol. | pmid:18495964 |
Hedenus M and Birgegård G | The role of iron supplementation during epoietin treatment for cancer-related anemia. | 2009 | Med. Oncol. | pmid:18473194 |
Willerson JT | Detection of acute myocardial infarcts by infarct-avid imaging. | 1991 | J. Nucl. Med. | pmid:1846912 |
Usmanov RI et al. | Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. | 2008 Mar-Apr | J. Nephrol. | pmid:18446719 |
pmid:18384797 | ||||
Aghaie A et al. | New insights into the alternative D-glucarate degradation pathway. | 2008 | J. Biol. Chem. | pmid:18364348 |
Auerbach M et al. | The role of intravenous iron in anemia management and transfusion avoidance. | 2008 | Transfusion | pmid:18346021 |
Lim R et al. | A permanent tan from iron. | 2008 | Kidney Int. | pmid:18340355 |
Perek N et al. | Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937. | 2008 | Eur. J. Nucl. Med. Mol. Imaging | pmid:18338166 |
Li H and Wang SX | Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. | 2008 Mar-Apr | Perit Dial Int | pmid:18332450 |
Earley CJ et al. | A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. | 2009 | Sleep Med. | pmid:18280205 |
Auerbach M and Al Talib K | Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. | 2008 | Kidney Int. | pmid:18274543 |
Bhatnagar R et al. | Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate. | 1991 | Biochem. Pharmacol. | pmid:1826840 |
Jaber BL | Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. | 2008 | Kidney Int. | pmid:18235527 |
Li H and Wang SX | Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. | 2008 | Blood Purif. | pmid:18212498 |